Arterys Cardio DL vs cmAngio®
AI Verdict
Choose Arterys Cardio DL if…
Choose Arterys Cardio DL if your primary need is to significantly accelerate and enhance the accuracy of cardiac MRI analysis. This tool is ideal for cardiologists and radiologists requiring automated, editable ventricle segmentations, 4D Flow post-processing, and quantitative delayed enhancement analysis to quickly assess cardiac function and morphology. It's best suited for high-volume imaging centers seeking to reduce interpretation time from minutes to seconds while maintaining diagnostic precision.
View Arterys Cardio DL →Choose cmAngio® if…
Choose cmAngio® if you aim to leverage existing mammography screenings for opportunistic cardiovascular risk assessment in women. This AI software is specifically designed to detect Breast Arterial Calcifications (BAC) on both FFDM and DBT exams, providing valuable insights into a patient's cardiovascular health without additional procedures or radiation. It is optimal for integrating a non-invasive cardiovascular risk indicator into routine breast imaging workflows.
View cmAngio® →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Arterys Cardio DL | cmAngio® |
|---|---|---|
| Pricing | Unknown | Paid, out-of-pocket |
| Deployment | Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27] | Cloud-based, integrates with any DICOM-compliant viewer |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Arterys Cardio DLArterys Cardio DL significantly enhances workflow by drastically reducing cardiac MRI interpretation time from minutes to seconds, improving efficiency and user experience through its cloud-based platform and editable automated contours. This rapid analysis, completing tasks in mere minutes that previously took 30-60 minutes, directly impacts clinical workflow and patient wait times.
Clinical Value
cmAngio®cmAngiou00ae offers a unique clinical value by leveraging existing mammograms to detect Breast Arterial Calcifications (BAC), providing crucial insights into cardiovascular health and aiding early risk assessment without additional radiation. Studies demonstrate that accurate, automated BAC identification can improve cardiovascular risk stratification, with BAC presence associated with significantly higher mortality and adverse cardiovascular outcomes.
Pricing & Value
TieBoth Arterys Cardio DL and cmAngiou00ae require direct contact with the vendor for pricing details, indicating a lack of public pricing transparency. While cmAngiou00ae mentions potential limited-time offers for no-cost implementation, this is not a guaranteed or permanent pricing structure, making a definitive comparison on value impossible without specific figures.
Enterprise Readiness
Arterys Cardio DLArterys Cardio DL demonstrates strong enterprise readiness with explicit HIPAA compliance, the availability of a Business Associate Agreement (BAA), and vendor-agnostic compatibility. Its cloud-based nature further simplifies integration into diverse healthcare IT infrastructures.
Innovation
Arterys Cardio DLArterys Cardio DL is recognized as a pioneer, being the first FDA-cleared technology to leverage cloud computing and deep learning in a clinical setting for medical imaging. It provides advanced features like 4D Flow post-processing and quantitative delayed enhancement analysis for complex cardiac MRI, pushing the boundaries of diagnostic capabilities.
Support & Docs
TieNeither the provided structured facts nor the web search results offered specific information regarding the availability, quality, or channels for customer support and documentation for either Arterys Cardio DL or cmAngiou00ae. Therefore, it is not possible to distinguish between the two tools on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Arterys Cardio DL | cmAngio® |
|---|---|---|
| Name | Arterys Cardio DL | cmAngiou00ae |
| Company | ARTERYS | CureMetrix |
| Primary Application | Automated, editable ventricle segmentations for cardiac MRI analysis | Detecting Breast Arterial Calcifications (BAC) on mammograms |
| Target Modality | Cardiac MRI | Mammograms (Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT)) |
| Specialties | Cardiology, Radiology | Cardiology, Obstetrics & Gynecology, Radiology |
| Key Feature Example | Automated ventricle segmentations for cardiac MRI | AI-based detection of Breast Arterial Calcifications (BAC) |
Videos
Demos, reviews, and walkthroughs featuring Arterys Cardio DL and cmAngio®.